{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:12:33Z","timestamp":1762431153273},"reference-count":69,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,7,17]]},"DOI":"10.1097\/qad.0000000000001108","type":"journal-article","created":{"date-parts":[[2016,4,19]],"date-time":"2016-04-19T17:24:14Z","timestamp":1461086654000},"page":"1691-1701","source":"Crossref","is-referenced-by-count":13,"title":["Development of synthetic light-chain antibodies as novel and potent HIV fusion inhibitors"],"prefix":"10.1097","volume":"30","author":[{"given":"Catarina","family":"Cunha-Santos","sequence":"first","affiliation":[]},{"given":"Tiago N.","family":"Figueira","sequence":"additional","affiliation":[]},{"given":"Pedro","family":"Borrego","sequence":"additional","affiliation":[]},{"given":"Soraia S.","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Cheila","family":"Rocha","sequence":"additional","affiliation":[]},{"given":"Andreia","family":"Couto","sequence":"additional","affiliation":[]},{"given":"C\u00e1tia","family":"Cantante","sequence":"additional","affiliation":[]},{"given":"Quirina","family":"Santos-Costa","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 M.","family":"Azevedo-Pereira","sequence":"additional","affiliation":[]},{"given":"Carlos M.G.A.","family":"Fontes","sequence":"additional","affiliation":[]},{"given":"Nuno","family":"Taveira","sequence":"additional","affiliation":[]},{"given":"Frederico","family":"Aires-Da-Silva","sequence":"additional","affiliation":[]},{"given":"Miguel A.R.B.","family":"Castanho","sequence":"additional","affiliation":[]},{"given":"Ana Salom\u00e9","family":"Veiga","sequence":"additional","affiliation":[]},{"given":"Joao","family":"Goncalves","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R1-4-20210130","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.2165\/00003495-200363240-00005","article-title":"Enfuvirtide","volume":"63","author":"Dando","year":"2003","journal-title":"Drugs"},{"key":"R2-4-20210130","doi-asserted-by":"crossref","first-page":"10537","DOI":"10.1073\/pnas.89.21.10537","article-title":"A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition","volume":"89","author":"Wild","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R3-4-20210130","doi-asserted-by":"crossref","first-page":"9770","DOI":"10.1073\/pnas.91.21.9770","article-title":"Peptides corresponding to a predictive a-helical domain of human immunodeficiency virus type 1 gp4l are potent inhibitors of virus infection","volume":"91","author":"Matthews","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R4-4-20210130","doi-asserted-by":"crossref","first-page":"a006866","DOI":"10.1101\/cshperspect.a006866","article-title":"HIV: cell binding and entry","volume":"2","author":"Wilen","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R5-4-20210130","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1128\/AAC.46.6.1896-1905.2002","article-title":"Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy","volume":"46","author":"Wei","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"R6-4-20210130","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/QAD.0b013e32835edc1d","article-title":"An ancestral HIV-2\/simian immunodeficiency virus peptide with potent HIV-1 and HIV-2 fusion inhibitor activity","volume":"27","author":"Borrego","year":"2013","journal-title":"AIDS"},{"key":"R7-4-20210130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3851\/IMP1369","article-title":"Current peptide HIV type-1 fusion inhibitors","volume":"20","author":"Pang","year":"2009","journal-title":"Antivir Chem Chemother"},{"key":"R8-4-20210130","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/341544a0","article-title":"Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli","volume":"341","author":"Ward","year":"1989","journal-title":"Nature"},{"key":"R9-4-20210130","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1016\/j.ddtec.2010.03.002","article-title":"Nanobodies: from llamas to therapeutic proteins","volume":"7","author":"Kolkman","year":"2010","journal-title":"Drug Discov Today Technol"},{"key":"R10-4-20210130","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1475-2859-10-44","article-title":"Biotechnological applications of recombinant single-domain antibody fragments","volume":"10","author":"de Marco","year":"2011","journal-title":"Microb Cell Fact"},{"key":"R11-4-20210130","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4161\/mabs.26844","article-title":"Antibody light chain variable domains and their biophysically improved versions for human immunotherapy","volume":"6","author":"Kim","year":"2014","journal-title":"MAbs"},{"key":"R12-4-20210130","first-page":"1011","article-title":"Expression, refolding, and ferritin-binding activity of the isolated VL-domain of monoclonal antibody F11","volume":"65","author":"Dubnovitsky","year":"2000","journal-title":"Biochemistry (Mosc"},{"key":"R13-4-20210130","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0022-2836(02)01237-8","article-title":"Biophysical properties of human antibody variable domains","volume":"325","author":"Ewert","year":"2003","journal-title":"J Mol Biol"},{"key":"R14-4-20210130","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/protein\/gzs014","article-title":"A VL single-domain antibody library shows a high-propensity to yield nonaggregating binders","volume":"25","author":"Hussack","year":"2012","journal-title":"Protein Eng Des Sel"},{"key":"R15-4-20210130","doi-asserted-by":"crossref","first-page":"17616","DOI":"10.1073\/pnas.0408134101","article-title":"Potent inhibition of huntingtin aggregation and cytotoxicity by a disulfide bond-free single-domain intracellular antibody","volume":"101","author":"Colby","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R16-4-20210130","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jmb.2011.09.034","article-title":"A disulfide-free single-domain VL intrabody with blocking activity towards huntingtin reveals a novel mode of epitope recognition","volume":"414","author":"Schiefner","year":"2011","journal-title":"J Mol Biol"},{"key":"R17-4-20210130","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/nar\/gkp1145","article-title":"Gene silencing by cell-penetrating, sequence-selective and nucleic-acid hydrolyzing antibodies","volume":"38","author":"Lee","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"R18-4-20210130","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1158\/1535-7163.MCT-05-0174","article-title":"Human single-domain neutralizing intrabodies directed against Etk kinase: a novel approach to impair cellular transformation","volume":"4","author":"Paz","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"R19-4-20210130","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0092-8674(00)80205-6","article-title":"Core structure of gp41 from the HIV envelope glycoprotein","volume":"89","author":"Chan","year":"1997","journal-title":"Cell"},{"key":"R20-4-20210130","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1042\/bj20031350","article-title":"Putative role of membranes in the HIV fusion inhibitor enfuvirtide mode of action at the molecular level","volume":"377","author":"Veiga","year":"2004","journal-title":"Biochem J"},{"key":"R21-4-20210130","doi-asserted-by":"crossref","first-page":"14724","DOI":"10.3390\/ijms140714724","article-title":"Effect of amphipathic HIV fusion inhibitor peptides on POPC and POPC\/cholesterol membrane properties: a molecular simulation study","volume":"14","author":"Martins do Canto","year":"2013","journal-title":"Int J Mol Sci"},{"key":"R22-4-20210130","doi-asserted-by":"crossref","first-page":"e9276","DOI":"10.1371\/journal.pone.0009276","article-title":"Novel HIV-1 knockdown targets identified by an enriched kinases\/phosphatases shRNA library using a long-term iterative screen in Jurkat T-cells","volume":"5","author":"Rato","year":"2010","journal-title":"PLoS One"},{"key":"R23-4-20210130","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.virol.2010.09.020","article-title":"Coreceptor usage by HIV-1 and HIV-2 primary isolates: the relevance of CCR8 chemokine receptor as an alternative coreceptor","volume":"408","author":"Calado","year":"2010","journal-title":"Virology"},{"key":"R24-4-20210130","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jmb.2004.04.062","article-title":"Camelized rabbit-derived VH single-domain intrabodies against Vif strongly neutralize HIV-1 infectivity","volume":"340","author":"Da Silva","year":"2004","journal-title":"J Mol Biol"},{"key":"R25-4-20210130","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1006\/viro.1994.1042","article-title":"Impairment of T cell receptor-dependent stimulation in CD4+ lymphocytes after contact with membrane-bound HIV-1 envelope glycoprotein","volume":"198","author":"Schwartz","year":"1994","journal-title":"Virology"},{"key":"R26-4-20210130","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3851\/IMP1996","article-title":"Baseline susceptibility of primary HIV-2 to entry inhibitors","volume":"17","author":"Borrego","year":"2012","journal-title":"Antivir Ther"},{"key":"R27-4-20210130","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/363446a0","article-title":"Naturally occurring antibodies devoid of light chains","volume":"363","author":"Hamers-Casterman","year":"1993","journal-title":"Nature"},{"key":"R28-4-20210130","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1073\/pnas.0505379103","article-title":"Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies","volume":"103","author":"De Genst","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R30-4-20210130","doi-asserted-by":"crossref","first-page":"32036","DOI":"10.1074\/jbc.M201906200","article-title":"Functional neutralization of HIV-1 Vif protein by intracellular immunization inhibits reverse transcription and viral replication","volume":"277","author":"Goncalves","year":"2002","journal-title":"J Biol Chem"},{"key":"R32-4-20210130","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/311074a0","article-title":"Immunoglobulin kappa light-chain diversity in rabbit is based on the 3\u2019 length heterogeneity of germ-line variable genes","volume":"311","author":"Heidmann","year":"1984","journal-title":"Nature"},{"key":"R33-4-20210130","first-page":"803","article-title":"Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme","volume":"3","author":"Momany","year":"1996","journal-title":"Nature"},{"key":"R34-4-20210130","doi-asserted-by":"crossref","first-page":"12467","DOI":"10.1073\/pnas.0401786101","article-title":"Synthetic antibodies from a four-amino-acid code: a dominant role for tyrosine in antigen recognition","volume":"101","author":"Fellouse","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R35-4-20210130","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1039\/b927393j","article-title":"The functional capacity of the natural amino acids for molecular recognition","volume":"6","author":"Birtalan","year":"2010","journal-title":"Mol Biosyst"},{"key":"R36-4-20210130","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1021\/cb800314v","article-title":"The importance of being tyrosine: lessons in molecular recognition from minimalist synthetic binding proteins","volume":"4","author":"Koide","year":"2009","journal-title":"ACS Chem Biol"},{"key":"R37-4-20210130","doi-asserted-by":"crossref","first-page":"15613","DOI":"10.1073\/pnas.95.26.15613","article-title":"Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target","volume":"95","author":"Chan","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R38-4-20210130","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1128\/JVI.72.2.986-993.1998","article-title":"Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides","volume":"72","author":"Rimsky","year":"1998","journal-title":"J Virol"},{"key":"R39-4-20210130","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1097\/00002030-200312050-00002","article-title":"Genetic diversity of HIV in Africa: impact on diagnosis, treatment, vaccine development and trials","volume":"17","author":"Peeters","year":"2003","journal-title":"AIDS"},{"key":"R40-4-20210130","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1128\/JVI.59.2.284-291.1986","article-title":"Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone","volume":"59","author":"Adachi","year":"1986","journal-title":"J Virol"},{"key":"R41-4-20210130","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1073\/pnas.0511136103","article-title":"The HIV lipidome: a raft with an unusual composition","volume":"103","author":"Br\u00fcgger","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R42-4-20210130","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.molstruc.2014.02.037","article-title":"The interaction of antibodies with lipid membranes unraveled by fluorescence methodologies","volume":"1077","author":"Figueira","year":"2014","journal-title":"J Mol Struct"},{"key":"R43-4-20210130","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.bbamem.2010.07.012","article-title":"Quantitative assessment of peptide-lipid interactions. Ubiquitous fluorescence methodologies","volume":"1798","author":"Matos","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"R44-4-20210130","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.4049\/jimmunol.150.7.2774","article-title":"Recombinant immunotoxins containing the VH or VL domain of monoclonal antibody B3 fused to Pseudomonas exotoxin","volume":"150","author":"Brinkmann","year":"1993","journal-title":"J Immunol"},{"key":"R45-4-20210130","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jmb.2004.07.054","article-title":"Development of a human light chain variable domain (V(L)) intracellular antibody specific for the amino terminus of huntingtin via yeast surface display","volume":"342","author":"Colby","year":"2004","journal-title":"J Mol Biol"},{"key":"R46-4-20210130","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1006\/jmbi.2001.4703","article-title":"Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains","volume":"310","author":"van den Beucken","year":"2001","journal-title":"J Mol Biol"},{"key":"R47-4-20210130","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0378-1119(95)00200-P","article-title":"Domain libraries: synthetic diversity for de novo design of antibody V-regions","volume":"160","author":"S\u00f6derlind","year":"1995","journal-title":"Gene"},{"key":"R48-4-20210130","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00430-009-0116-7","article-title":"Single domain antibodies: promising experimental and therapeutic tools in infection and immunity","volume":"198","author":"Wesolowski","year":"2009","journal-title":"Med Microbiol Immunol"},{"key":"R49-4-20210130","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/387426a0","article-title":"Atomic structure of the ectodomain from HIV-1 gp41","volume":"387","author":"Weissenhorn","year":"1997","journal-title":"Nature"},{"key":"R50-4-20210130","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/01.qai.0000234083.34161.55","article-title":"Rapid emergence of enfuvirtide resistance in HIV-1-infected patients: results of a clonal analysis","volume":"43","author":"Lu","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R51-4-20210130","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1021\/bi1005267","article-title":"Alanine scanning mutagenesis of HIV-1 gp41 heptad repeat 1: insight into the gp120-gp41 interaction","volume":"49","author":"Sen","year":"2010","journal-title":"Biochemistry"},{"key":"R52-4-20210130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/135965350400900115","article-title":"Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis","volume":"9","author":"Witvrouw","year":"2004","journal-title":"Antivir Ther"},{"key":"R53-4-20210130","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/QAD.0b013e328342ff11","article-title":"Anti-HIV-1 antibodies 2F5 and 4E10 interact differently with lipids to bind their epitopes","volume":"25","author":"Franquelim","year":"2011","journal-title":"AIDS"},{"key":"R54-4-20210130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2009.07.022","article-title":"Ligands, their receptors and ... plasma membranes","volume":"311","author":"Vauquelin","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"R55-4-20210130","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/COH.0000000000000049","article-title":"Autoreactivity in HIV-1 broadly neutralizing antibodies: implications for their function and induction by vaccination","volume":"9","author":"Verkoczy","year":"2014","journal-title":"Curr Opin HIV AIDS"},{"key":"R56-4-20210130","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1084\/jem.20121827","article-title":"Neutralizing antibodies to HIV-1 induced by immunization","volume":"210","author":"McCoy","year":"2013","journal-title":"J Exp Med"},{"key":"R57-4-20210130","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1084\/jem.20112655","article-title":"Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunization","volume":"209","author":"McCoy","year":"2012","journal-title":"J Exp Med"},{"key":"R58-4-20210130","doi-asserted-by":"crossref","first-page":"12069","DOI":"10.1128\/JVI.01379-08","article-title":"Llama antibody fragments with cross-subtype human immunodeficiency virus type 1 (HIV-1)-neutralizing properties and high affinity for HIV-1 gp120","volume":"82","author":"Forsman","year":"2008","journal-title":"J Virol"},{"key":"R59-4-20210130","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1371\/journal.pone.0010482","article-title":"Crystal Structure of the neutralizing Llama VHH D7 and its mode of HIV-1 gp120 interaction","volume":"5","author":"Hinz","year":"2010","journal-title":"PLoS One"},{"key":"R60-4-20210130","doi-asserted-by":"crossref","first-page":"19116","DOI":"10.1074\/jbc.M110.116699","article-title":"Generation of a family-specific phage library of llama single chain antibody fragments that neutralize HIV-1","volume":"285","author":"Koh","year":"2010","journal-title":"J Biol Chem"},{"key":"R61-4-20210130","doi-asserted-by":"crossref","first-page":"e33298","DOI":"10.1371\/journal.pone.0033298","article-title":"Llama antibody fragments recognizing various epitopes of the CD4bs neutralize a broad range of HIV-1 subtypes A, B and C","volume":"7","author":"Strokappe","year":"2012","journal-title":"PLoS One"},{"key":"R62-4-20210130","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.copbio.2011.06.012","article-title":"Strategies for extended serum half-life of protein therapeutics","volume":"22","author":"Kontermann","year":"2011","journal-title":"Curr Opin Biotechnol"},{"key":"R63-4-20210130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nucmedbio.2014.01.009","article-title":"Biodistribution of a 67Ga-labeled anti-TNF VHH single-domain antibody containing a bacterial albumin-binding domain (Zag)","volume":"41","author":"Morais","year":"2014","journal-title":"Nucl Med Biol"},{"key":"R64-4-20210130","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1073\/pnas.90.11.5181","article-title":"Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes","volume":"90","author":"Aloia","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R66-4-20210130","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1073\/pnas.81.6.1794","article-title":"Kappa-chain allotypes and isotypes in the rabbit: cDNA sequences of clones encoding b9 suggest an evolutionary pathway and possible role of the interdomain disulfide bond in quantitative allotype expression","volume":"81","author":"McCartney-Francis","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R67-4-20210130","doi-asserted-by":"crossref","first-page":"8289","DOI":"10.1128\/JVI.00709-09","article-title":"Evidence that ecotropic murine leukemia virus contamination in TZM-bl cells does not affect the outcome of neutralizing antibody assays with human immunodeficiency virus type 1","volume":"83","author":"Platt","year":"2009","journal-title":"J Virol"},{"key":"R68-4-20210130","doi-asserted-by":"crossref","first-page":"12585","DOI":"10.1128\/JVI.01726-08","article-title":"Identification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus research","volume":"82","author":"Takeuchi","year":"2008","journal-title":"J Virol"},{"key":"R69-4-20210130","doi-asserted-by":"crossref","first-page":"8358","DOI":"10.1128\/JVI.74.18.8358-8367.2000","article-title":"Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120","volume":"74","author":"Derdeyn","year":"2000","journal-title":"J Virol"},{"key":"R70-4-20210130","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/JVI.72.4.2855-2864.1998","article-title":"Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1","volume":"72","author":"Platt","year":"1998","journal-title":"J Virol"},{"key":"R71-4-20210130","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1128\/JVI.66.4.2232-2239.1992","article-title":"Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene","volume":"66","author":"Kimpton","year":"1992","journal-title":"J Virol"},{"key":"R72-4-20210130","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4049\/jimmunol.133.1.123","article-title":"The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pretranslational level","volume":"133","author":"Weiss","year":"1984","journal-title":"J Immunol"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAD.0000000000001108","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T21:17:16Z","timestamp":1718486236000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-201607170-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,17]]},"references-count":69,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0000000000001108","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7,17]]}}}